Organigram Global Inc.
Reports in 16d· 2026-05-13
-12.7% · 90d
$1.44
-0.00 (-0.35%)
After-Hours $1.46(+0.02)
News
(1)March 2026
ORGANIGRAM GLOBAL INC. — 6-K Filing
OGIORGANIGRAM GLOBAL INC.
# 🧾 What This Document Is This is a **6-K filing**, which is a report foreign companies like Canadian-based Organigram must file with the SEC to share major news with U.S. investors. This specific report announces two things: 1) Their shareholders have officially approved a major acquisition, and 2
Read summaryView on SEC EDGAR
Peers in Drug Manufacturers - Specialty & Generic
TAK#1
Takeda Pharmaceutical Company Limited
$57.78B-1.07%
ZTS#2
Zoetis Inc.
$50.46B+0.20%
HLN#3
Haleon plc
$43.61B+0.40%
TEVA#4
Teva Pharmaceutical Industries Limited
$36.05B+1.44%
UTHR#5
United Therapeutics Corporation
$25.19B-1.19%
VTRS#6
Viatris Inc.
$15.85B+0.29%
RGC#7
Regencell Bioscience Holdings Limited
$13.93B-2.46%
NBIX#8
Neurocrine Biosciences, Inc.
$13.21B-1.13%
ELAN#9
Elanco Animal Health Incorporated
$11.66B-0.59%
RDY#10
Dr. Reddy's Laboratories Limited
$10.92B+0.15%